ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "autoimmune diseases and systemic lupus erythematosus (SLE)"

  • Abstract Number: 1015 • 2019 ACR/ARP Annual Meeting

    Evidence for Substantial Immune Activation in Asymptomatic ANA Positive Individuals

    Emma Van Lieshout1, Dennisse Bonilla 2, Zahi Touma 3, Arthur Bookman 4, Linda Hiraki 5, Zareen Ahmad 6, Sindhu Johnson 7, Earl D. Silverman 8 and Joan Wither 9, 1University of Toronto, Toronto, ON, Canada, 2University Health Network, University of Toronto, Toronto, ON, Canada, 3University Health Network, University of Toronto, Toronto, Canada, 4University Health Network - Toronto Western Hospital, Toronto, Canada, 5The Hospital for Sick Children, Toronto, Canada, 6Mount Sinai Hospital, Toronto, Canada, 7Toronto Scleroderma Program, Department of Medicine, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Canada, Toronto, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 9University Health Network, Krembil Research Institute, Toronto, ON, Canada

    Background/Purpose: Systemic autoimmune rheumatic diseases (SARD) including Sjogren’s Disease (SjD), Systemic Sclerosis (SSc) and Systemic Lupus Erythematosus (SLE) are characterized by the production of anti-nuclear…
  • Abstract Number: 2658 • 2017 ACR/ARHP Annual Meeting

    4-Hydroxy-2-Nonenal Serum Protein-Adducts and Anti-4-Hydroxy-2-Nonenal-Protein Adduct Antibodies in SLE

    Biji T Kurien1,2,3 and R. Hal Scofield4, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 3College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, complex disease and autoantibodies to self-antigens are a characteristic feature of the disorder. Our group and others…
  • Abstract Number: 883 • 2013 ACR/ARHP Annual Meeting

    Sex Bias In Autoimmune Diseases: Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjögren’s Syndrome (SS) Supports The Gene Dose Hypothesis

    Ke Liu1, Kenneth M. Kaufman2,3, Judith A. James4,5, Roland Jonsson6,7, Biji T. Kurien4,5,8, Xavier Mariette9, Joan T. Merrill10, Roald Omdal11, Maureen Rischmueller12,13, Timothy J. Vyse14, Marie Wahren-Herlenius15, Torsten Witte16, Christopher J. Lessard4,5, Sarah L. Zimmerman17, Susan D. Thompson18, Gideon Hirschfield19, Gang Xie20,21, Courtney G. Montgomery8,22, Wan-Fai Ng23, Gunnel Nordmark24, Patrick M. Gaffney4,8, Katherine A. Siminovitch20,25, Kathy L. Sivils4,26, Slegen (International Consortium For The Genetics Of SLE)27 and R. Hal Scofield4,5,28, 1Center for Autoimmune Genomics and Etiology and Rheumatology Division, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, Cincinnati, OH, 2U.S. Department of Veterans Affairs Medical Center, Cincinnati, OH, 31Center for Autoimmune Genomics and Etiology and Rheumatology Division, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, Cincinnati, OH, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 6Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 7Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 8U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 9Paris-Sud University, Paris, France, 10Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 11Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 12Rheumatology Department, Queen Elizabeth Hospital, Adelaide, Australia, 13Discipline of Medicine, University of Adelaide, Adelaide, Australia, 14Division of Genetics and Molecular Medicine and Division of Immunology, Infection and Inflammatory Disease, King's College London, London, United Kingdom, 15Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 16Clinical Immunology and Rheumatology, Medical University Hannover, Hanover, Germany, 17Divison of human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 18Division and Center for Autoimmune Disease Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 19Centre for Liver Research, Institute of Biomedical Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 20Mount Sinai Hospital, Toronto, ON, Canada, 21University Of Toronto, Toronto, ON, Canada, 22Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 23Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle upon Tyne, United Kingdom, 24Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 25University of Toronto, Toronto, ON, Canada, 26University of Oklahoma Health Sciences Center, Oklahoma City, OK, 27Center for Autoimmune Genomics and Etiology and Rheumatology Division, International Consortium For The Genetics Of Systemic Lupus Erythematosus, Cincinnati, OH, 28US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Female preponderance is a hallmark of most autoimmune diseases, the mechanism for which is unknown. We hypothesize that this is a consequence of a…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies